EGFR and cancer: This agreement suggests that the nuclear translocation of EGFR by the activation of Src family kinases might be a general mechanism of endurance to various stresses, and might be beneficial for the expansion of cancer cells that can inherently overcome the stresses involving molecular targeted therapies.